Stay informed with the latest updates for the inheritable blood disorders community. Medical Gilead’s Harvoni®, First HCV Combination Pill, Approved by FDAOct 16, 2014 Medical PDF Now Available for Nurses’ Guide Chapter on ProphylaxisOct 16, 2014 Advocacy & Legislative HHS Announces 2015 Medicare Part B Premiums, Deductibles Remain UnchangedOct 10, 2014 Industry Enroll Now in HCV Clinical Trial for People with HemophiliaOct 7, 2014 Advocacy & Legislative FDA Holds Novel Patient-Focused Meeting on Bleeding DisordersSep 30, 2014 Industry Grifols Announces Larger Vial Size for ALPHANATE®Sep 29, 2014 Industry FDA Approves Baxter’s RIXUBIS for Children with Hemophilia BSep 25, 2014 NBDF & Community Relive Historic Annual Meeting Session on…Sep 25, 2014 NBDF & Community Did You Make a Capital Connection at NHF's Annual Meeting in DC?Sep 25, 2014 Industry Researchers Report Advances in Plant-based Hemophilia A TherapySep 10, 2014 Industry Achillion’s New HCV Treatment Performing Well in Phase 2 TrialSep 3, 2014 Industry Expression and ABL to Develop and Market High-Yield, Low-Cost rFVIIISep 3, 2014 Industry BAX 855 Performs Well Prophylactically in Phase 3 TrialAug 25, 2014 NBDF & Community Fred T. Ferguson, Former NHF Board Member and Volunteer, Passes AwayAug 25, 2014 Industry BeneFIX® Performs Well in Prophylaxis TrialJul 28, 2014 Pagination First page Previous page … Page 71 Page 72 Page 73 Page 74 Current page 75 Page 76 Page 77 Page 78 Page 79 … Next page Last page
